Current and Emerging Medical Therapies for Dizziness.
Central vertigo
Dizziness
Peripheral vertigo
Pharmacotherapy
Journal
Otolaryngologic clinics of North America
ISSN: 1557-8259
Titre abrégé: Otolaryngol Clin North Am
Pays: United States
ID NLM: 0144042
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
entrez:
20
9
2021
pubmed:
21
9
2021
medline:
26
11
2021
Statut:
ppublish
Résumé
Medical therapies for dizziness are aimed at vertigo reduction, secondary symptom management, or the root cause of the pathologic process. Acute peripheral vertigo pharmacotherapies include antihistamines, calcium channel blockers, and benzodiazepines. Prophylactic pharmacotherapies vary between causes. For Meniere disease, betahistine and diuretics remain initial first-line oral options, whereas intratympanic steroids and intratympanic gentamicin are reserved for uncontrolled symptoms. For cerebellar dizziness and oculomotor disorders, 4-aminopyridine may provide benefit. For vestibular migraine, persistent postural perceptual dizziness and mal de débarquement, treatment options overlap and include selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants and calcium channel blockers.
Identifiants
pubmed: 34538357
pii: S0030-6665(21)00120-1
doi: 10.1016/j.otc.2021.05.019
pii:
doi:
Substances chimiques
Histamine Antagonists
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1037-1056Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.